Personalized patient engagement.
Significantly better outcomes.

Improve the overall experience through tailored communications to patients on your therapy.

Reimbursement and Treatment Initiation

Adherence Programs

Patient Services Infrastructure

Omnichannel Nurse Support

Contact Center and Field Force Platform

Patient CRM and Digital Engagement

Patient Support Programs

Product Launch Support

As a pharmaceutical or biotech company, you want patients to succeed on your therapy. However, they can experience barriers—emotional, logistical, and financial and more—that get in the way of treatment. Human Care Systems understands these roadblocks. That’s why we developed our Resilix™ CRM platform, that delivers personalized, omnichannel patient communications to improve initiation, adherence, and persistence. Drive disease awareness and diagnosis, reimbursement support, and patient support programs with the Resilix™, the treatment experience platform.

Resilix Treatment Experience Platform

Treatment Experience Nurses

What our clients are saying

How HCS improved the patient experience for a top-5 pharmaceutical company.

We deliver results


IMPROVED Adherence
To Hepatitis C Therapy

High Satisfaction
for patients in our programs

Improved Outcomes
For insulin pump users; lowered a1c levels

Of patients said our programs helped them take their medication as prescribed.


Patients Supported


Patient Populations


Return on Investment

A few of our clients who are improving the patient experience

What patients are saying

“Most medicine doesn’t make you feel very special or individualized. This whole process has me…hopeful. It makes it feel like it is individualized.”

“I feel like I have a coach. It’s a good thing and a big deal. It’s nice to know that someone other than my family members are taking an interest in my continued health and improvement.”

Contact us today!

See how Human Care Systems can deliver tailored communications to support your patients and HCPs.

  • This field is for validation purposes and should be left unchanged.